WHO ICTRP trial

Comparative Study of Sugammadex and Neostigmine on Early Postoperative…

CTRI/2025/10/095799 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/10/095799
Public title Comparative Study of Sugammadex and Neostigmine on Early Postoperative Respiratory Recovery in Elderly Patients
Scientific title Impact of reversal of neuromuscular blockade with Sugammadex vs Neostigmine on early postoperative respiratory muscle function in geriatric population - Nil
Primary sponsor Himalayan Institute of Medical Sciences
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type PMS
Phase Phase 3/ Phase 4
Countries India
Conditions Health Condition 1: M96-M96- Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
Interventions Control Intervention1: Injection Neostigmine: 0.05mg/kg intravenous single dose after completion of surgery prior to extubation Control Intervention2: Injection Sugammadex: 2mg/kg intravenous single dose after completion of surgery prior to…
Registration date Sep 10, 2025
Target size 100
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations